Iga Swiatek has spoken out about comparisons being drawn between the allegations she broke WADA rules and the accusations that have been level at other tennis players, asserting that “each of these cases is completely different.” The reigning French Open champion tested positive for the banned substance trimetazidine in August ahead of the Cincinnati Open.
Last week, the International Tennis Integrity Agency (ITIA) announced that Swiatek had been handed a one-month suspension, citing “no significant fault or negligence.” The Polish star explained that the substance entered her system due to contamination in the non-prescription medication she used for jet lag and sleep issues—a rationale accepted by the ITIA.
Swiatek’s suspension, retroactively applied from September 12 to October 4, meant she had already served 22 days of her ban when the announcement was made. During this period, she missed major WTA events in Wuhan and Beijing, citing reasons other than a ban. The world #2 returned to competitive action at the WTA Finals in Riyadh in November and concluded her season at the Billie Jean King Cup Finals in Malaga. Swiatek will compete at the United Cup and the Australian Open in January.
In a recent interview on the Polish TV channel TVN24, Swiatek acknowledged the concerns raised by players like the 33-year-old, who have criticized inconsistencies in how doping cases are handled. Halep and British doubles player Tara Moore both argued that some players appear to receive faster or more favorable resolutions.
“I know that people need to automatically compare such situations to others that have already happened, but the truth is that each of these cases is completely different,” said the 23-year-old. “And the process of proving innocence will also be different.
“It’s hard to compare me to Sinner, to Halep, to Kamil Majchrzak, because each of us is struggling with a different problem,” she added.
Swiatek emphasized the critical role of the ITIA in determining outcomes, saying, “My fate, just like the fates of others, was in their hands, and they decide how each case will turn out. I trust that this process is objective, that everything is done according to the regulations, and no one judges a player this way or that way because of his position. But whether it is really like that, I think this is a question for ITIA.”
The recent doping cases of Swiatek and others have reignited debates about anti-doping processes in tennis. ATP world No. 1 Jannik Sinner avoided suspension after twice testing positive for clostebol in March. However, the World Anti-Doping Agency (WADA) has appealed the decision to the Court of Arbitration for Sport (CAS).
Simona Halep, a two-time Grand Slam champion, was handed a four-year ban in 2023 for testing positive for the blood-doping agent roxadustat at the 2022 US Open. After appealing to CAS, her ban was reduced to nine months, allowing her immediate return to competition.
Main photo credit: Mike Frey-USA TODAY Sports
